---
$id: https://graph.org.ai/products/commodity/51101640
$type: Product
source: UNSPSC
code: "51101640"
title: "Broxyquinoline"
class: "51101600"
classTitle: "Amebicides and trichomonacides"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Broxyquinoline

**UNSPSC Code**: 51101640
**Class**: [Amebicides and trichomonacides](Amebicides and trichomonacides.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-infective agent with the molecular formula C9H5Br2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UK4C618C8T, chemically known as 5,7-dibromooxine but generally known as broxyquinoline, which bears US NIH Compound Identifier 2453. European Medicines Agency schedules Broxyquinoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05940MIG. The term BROXYQUINOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules broxyquinoline in its Anatomical Therapeutic Chemical (ATC) Classification. BROXYQUINOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule broxyquinoline under HS 29334990 and SITC 51575. As of Q4 2014, BROXYQUINOLINE remains the US FDA Preferred Term for this commodity. Broxyquinoline bears US NLM identifiers UMLS ID C0054157 and NCI Concept Code C73253. SMILES: BRC1C2C(NCCC2)C(O)C(BR)C1.

